New Insights into Serotonin 5-HT4 Receptors : A Novel Therapeutic Target for Alzheimers Disease?

Author(s): Marjorie Maillet, Sylvain J. Robert, Frank Lezoualc'h.

Journal Name: Current Alzheimer Research

Volume 1 , Issue 2 , 2004

Become EABM
Become Reviewer

Abstract:

The serotonin 5-HT4 receptor mediates many physiological effects in the central nervous system. The recent molecular identification of 5-HT4 receptors and the development of selective 5-HT4 receptor ligands have led to many important new insights into the signalling pathways and the physiological roles of these G protein-coupledreceptors in neurones. With respect to neurodegenerative disorders, it is suggested that 5-HT4 agonists may represent a new avenue for the treatment of Alzheimers disease. This mini-review will focus on recent in vitro and in vivo pharmacological and biochemical studies showing the involvement of 5-HT4 receptors in cognitive processes and the amyloid precursor protein processing. The potential use of 5-HT4 agonists for the treatment of AD will be discussed.

Keywords: acetylcholine, memory, alzheimer disease, serotonin 5-ht4, receptor, amyloid precursor protein, small g proteins, camp

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 1
ISSUE: 2
Year: 2004
Page: [79 - 85]
Pages: 7
DOI: 10.2174/1567205043332252
Price: $58

Article Metrics

PDF: 6